ES494933A0 - Un procedimiento para la preparacion de 4-(tiazolil sustituido)-3-hidroxi-3-pinrolin 2,5.dionas inhibodoras de la acido glicolico oxidasa. - Google Patents

Un procedimiento para la preparacion de 4-(tiazolil sustituido)-3-hidroxi-3-pinrolin 2,5.dionas inhibodoras de la acido glicolico oxidasa.

Info

Publication number
ES494933A0
ES494933A0 ES494933A ES494933A ES494933A0 ES 494933 A0 ES494933 A0 ES 494933A0 ES 494933 A ES494933 A ES 494933A ES 494933 A ES494933 A ES 494933A ES 494933 A0 ES494933 A0 ES 494933A0
Authority
ES
Spain
Prior art keywords
diones
glycolic acid
substituted
pinrolin
inhibodore
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES494933A
Other languages
English (en)
Spanish (es)
Other versions
ES8105996A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES8105996A1 publication Critical patent/ES8105996A1/es
Publication of ES494933A0 publication Critical patent/ES494933A0/es
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/30—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES494933A 1979-09-11 1980-09-10 Un procedimiento para la preparacion de 4-(tiazolil sustituido)-3-hidroxi-3-pinrolin 2,5.dionas inhibodoras de la acido glicolico oxidasa. Granted ES494933A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/074,465 US4298743A (en) 1979-09-11 1979-09-11 4-(Substituted phenyl thiazolyl)-3-hydroxy-3-pyrroline-2,5-diones

Publications (2)

Publication Number Publication Date
ES8105996A1 ES8105996A1 (es) 1981-07-01
ES494933A0 true ES494933A0 (es) 1981-07-01

Family

ID=22119703

Family Applications (1)

Application Number Title Priority Date Filing Date
ES494933A Granted ES494933A0 (es) 1979-09-11 1980-09-10 Un procedimiento para la preparacion de 4-(tiazolil sustituido)-3-hidroxi-3-pinrolin 2,5.dionas inhibodoras de la acido glicolico oxidasa.

Country Status (9)

Country Link
US (1) US4298743A (enExample)
EP (1) EP0025232B1 (enExample)
JP (1) JPS5646809A (enExample)
AT (1) ATE2271T1 (enExample)
DE (1) DE3061688D1 (enExample)
DK (1) DK384280A (enExample)
ES (1) ES494933A0 (enExample)
GR (1) GR70200B (enExample)
PT (1) PT71755B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4379791A (en) * 1979-09-11 1983-04-12 Merck & Co., Inc. 4-(Substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase
US4700901A (en) * 1985-08-19 1987-10-20 Breville R & D Pty. Limited Food processors
EP0513387B1 (en) * 1990-11-30 2000-03-01 Otsuka Pharmaceutical Co., Ltd. Thiazole derivatives as active oxygen inhibitors
MY128323A (en) * 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US6313156B1 (en) 1999-12-23 2001-11-06 Icos Corporation Thiazole compounds as cyclic-AMP-specific phosphodiesterase inhibitors
DE10029077A1 (de) * 2000-06-13 2001-12-20 Bayer Ag Thiazolylsubstituierte Heterocyclen
EP2181985B1 (en) * 2001-08-10 2011-10-26 Shionogi & Co., Ltd. Antiviral Agent
US6858614B2 (en) * 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenolic guanidine sodium channel blockers
US6858615B2 (en) 2002-02-19 2005-02-22 Parion Sciences, Inc. Phenyl guanidine sodium channel blockers
US7144911B2 (en) 2002-12-31 2006-12-05 Deciphera Pharmaceuticals Llc Anti-inflammatory medicaments
US7279576B2 (en) 2002-12-31 2007-10-09 Deciphera Pharmaceuticals, Llc Anti-cancer medicaments
US7202257B2 (en) 2003-12-24 2007-04-10 Deciphera Pharmaceuticals, Llc Anti-inflammatory medicaments
US6903105B2 (en) 2003-02-19 2005-06-07 Parion Sciences, Inc. Sodium channel blockers
US7745442B2 (en) 2003-08-20 2010-06-29 Parion Sciences, Inc. Methods of reducing risk of infection from pathogens
WO2006071940A2 (en) 2004-12-23 2006-07-06 Deciphera Pharmaceuticals, Llc Enzyme modulators and treatments
US8188113B2 (en) 2006-09-14 2012-05-29 Deciphera Pharmaceuticals, Inc. Dihydropyridopyrimidinyl, dihydronaphthyidinyl and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
US7790756B2 (en) 2006-10-11 2010-09-07 Deciphera Pharmaceuticals, Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
SG183054A1 (en) 2007-04-20 2012-08-30 Deciphera Pharmaceuticals Llc Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
KR20110099687A (ko) 2008-10-29 2011-09-08 데시페라 파마슈티칼스, 엘엘씨. 항-암과 항-증식성 활성을 나타내는 시클로프로판 아미드와 유사체
AR086745A1 (es) 2011-06-27 2014-01-22 Parion Sciences Inc 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil)carbamimidoil)pirazina-2-carboxamida
US8461179B1 (en) 2012-06-07 2013-06-11 Deciphera Pharmaceuticals, Llc Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
MX2015007797A (es) 2012-12-17 2015-10-05 Parion Sciences Inc Compuestos de 3,5-diamino-6-cloro-n-(n-(4-fenilbutil) carbamimidoil) pirazin-2-carboxamida.
RU2015129065A (ru) 2012-12-17 2017-01-25 Пэрион Сайенсиз, Инк. Производные хлор-пиразинкарбоксамида, обладающие активностью блокирования эпителиальных натриевых каналов
US9102633B2 (en) 2013-12-13 2015-08-11 Parion Sciences, Inc. Arylalkyl- and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
KR102708050B1 (ko) 2018-01-31 2024-09-24 데시페라 파마슈티칼스, 엘엘씨. 비만 세포증의 치료를 위한 병용 요법
SG11202007198WA (en) 2018-01-31 2020-08-28 Deciphera Pharmaceuticals Llc Combination therapy for the treatment of gastrointestinal stromal tumors
EP3938363A1 (en) 2019-03-11 2022-01-19 Teva Pharmaceuticals International GmbH Solid state forms of ripretinib
WO2021030405A1 (en) 2019-08-12 2021-02-18 Deciphera Pharmaceuticals, Llc Ripretinib for treating gastrointestinal stromal tumors
CN114615982A (zh) 2019-08-12 2022-06-10 德西费拉制药有限责任公司 用于治疗胃肠道间质瘤的瑞普替尼
CN118948772A (zh) 2019-12-30 2024-11-15 德西费拉制药有限责任公司 1-(4溴-5-(1乙基-7-(甲氨基)-2侧氧基-1,2-二氢-1,6-萘啶-3基)-2氟苯基)-3-苯基脲的组合物
MX2022008103A (es) 2019-12-30 2022-09-19 Deciphera Pharmaceuticals Llc Formulaciones de inhibidores de la cinasa amorfa y metodos de estas.
US11779572B1 (en) 2022-09-02 2023-10-10 Deciphera Pharmaceuticals, Llc Methods of treating gastrointestinal stromal tumors

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE599556A (enExample) * 1960-02-01
US3340263A (en) * 1964-02-14 1967-09-05 Ciba Geigy Corp Amino-pyrroles
GB1127875A (en) * 1967-03-23 1968-09-18 Parke Davis & Co 4-(5-nitro-2-furyl) thiazolyl hydantoins and hydrouracils
GB1304174A (enExample) * 1969-03-07 1973-01-24

Also Published As

Publication number Publication date
JPS5646809A (en) 1981-04-28
ES8105996A1 (es) 1981-07-01
PT71755A (en) 1980-09-01
EP0025232B1 (en) 1983-01-19
DK384280A (da) 1981-03-12
DE3061688D1 (en) 1983-02-24
GR70200B (enExample) 1982-08-31
US4298743A (en) 1981-11-03
EP0025232A1 (en) 1981-03-18
PT71755B (en) 1982-03-19
ATE2271T1 (de) 1983-02-15

Similar Documents

Publication Publication Date Title
ES494933A0 (es) Un procedimiento para la preparacion de 4-(tiazolil sustituido)-3-hidroxi-3-pinrolin 2,5.dionas inhibodoras de la acido glicolico oxidasa.
ES492310A0 (es) Un procedimiento para la preparacion de nuevas 3-hidroxi-3- pirrolin-2, 5-dionas-4-sustituidas
ES484124A0 (es) Procedimiento para la preparacion de una composicion homoge-nea destinada al tratamiento de materias fibrosas.
NO882200D0 (no) Fremgangsmaate for fremstilling av kalsiumsulfat-alfa-halvhydrat.
ES529315A0 (es) Procedimiento para la preparacion de 3-(1-sustituido-4-piperidil)-1, 2-bencisoxazoles
ES2013631B3 (es) Metodo para el tratamiento de tejidos.
ES2021411B3 (es) Proceso para la preparacion de (2,2) paraciclofano.
AR231638A1 (es) Procedimiento para obtener compuestos de 1-1-2-(1,4-benzoxatio o 1,4-benzoxatian o 1,4-benzodioxan-2-il)-alquilen-4-piperidil-2-imidazolinona,2-hexahidro-pirimidinona o 2-imino-imidazolidina
FI875684A7 (fi) 1,1,2,2-tetrahydroperfluorialkanolien ja niiden estereiden valmistusmenetelmä.
NL7801813A (nl) Werkwijze voor de bereiding van polyesters van 1,2-di(hydroxyfenyl)ethaanverbindingen en aroma- tische dicarbonzuren.
BR8905745A (pt) Composicao de fragrancia,processo para a preparacao de compostos e uso dos ditos compostos
ES488232A0 (es) Un procedimiento para la reduccion de un sulfoxido de cefa- losporina
ES537832A0 (es) Procedimiento para la deshidratacion de 2,6-dimetilmorfolina
ES2023395B3 (es) Procedimiento para el condicionamiento de desechos secos, bionocivos.
ES516605A0 (es) "procedimiento para la produccion o tratamiento de ferrocromo".
AR218549A1 (es) Procedimiento para la preparacion del 2,6-dimetil-4-(3-nitrofenil)-3-metoxi-carbonil-1,4-dihidropiridin-5-carboxilato de 2-(n-bencil-n-metilamino)etilo
ES555536A0 (es) Procedimiento para la obtencion de nuevos derivados de 3-mercapto-1,2,4-triazacicloalcadieno.
AR226343A1 (es) Procedimiento para la preparacion de acidos 3-(2-halogeno-(o 2,6-dihalogeno)-4-trifluormetil-fenoxi)benzoicos
ES509853A0 (es) "procedimiento para la preparacion de derivados de 4-(5)-alcohil-mercaptoimidazoles".
ES492796A0 (es) Procedimiento para la preparacion de 4-oxa-6-aza-6(fenil-es-piro)(2.4)heptan-5,7-dionas
ES1008390Y (es) Horma perfeccionada para la fabricacion de calzado.
ES494141A0 (es) Procedimiento para la preparacion de 4-aril-5,6,7,8-tetrahi-dropirazolo (3,4b) (1,5) diazepin-1h,4h-5,7-dionas
ES2019857A4 (es) Aminopropanolderivados de compuestos de 3-(2-hidroxifenil)-1-propanona, procedimientos para su obtencion y medicamentos que los contienen.
ES554120A0 (es) Procedimiento para la obtencion de esteres de acidos 3-(2,2-dihalovinil)-2,2-dimetilciclppropanocarboxilicos
ES557132A0 (es) Procedimiento para la obtencion de isocianatos piperidinicos.